CY1109146T1 - Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα - Google Patents

Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα

Info

Publication number
CY1109146T1
CY1109146T1 CY20091100624T CY091100624T CY1109146T1 CY 1109146 T1 CY1109146 T1 CY 1109146T1 CY 20091100624 T CY20091100624 T CY 20091100624T CY 091100624 T CY091100624 T CY 091100624T CY 1109146 T1 CY1109146 T1 CY 1109146T1
Authority
CY
Cyprus
Prior art keywords
administration
container containing
containing nicotine
liquid medicinal
oral dental
Prior art date
Application number
CY20091100624T
Other languages
English (en)
Inventor
Katarina Lindell
Bengt Bosson
Gunnar Bergengren
Anette Schlüter
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20286485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1109146(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of CY1109146T1 publication Critical patent/CY1109146T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ένα υγρό φαρμακευτικό σκεύασμα το οποίο περιλαμβάνει νικοτίνη σε οποιαδήποτε μορφή για την χορήγηση στην στοματική κοιλότητα το οποίο γίνεται αλκαλικό με ρύθμιση ή/και προσαρμογή του pΗ. Η χορήγηση γίνεται κατά προτίμηση με ψεκασμό και κατά μέγιστη προτίμηση με ψεκασμό κάτω από την γλώσσα. Μία μέθοδος για την κατασκευή του εν λόγω σκευάσματος. Η χρήση του εν λόγω σκευάσματος σε θεραπεία, όπως η θεραπεία για την θεραπευτική αντιμετώπιση του εθισμού στον καπνό.
CY20091100624T 2001-12-27 2009-06-12 Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα CY1109146T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104388A SE0104388D0 (sv) 2001-12-27 2001-12-27 New formulation and use and manufacture thereof
EP02793665A EP1458388B1 (en) 2001-12-27 2002-12-18 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity

Publications (1)

Publication Number Publication Date
CY1109146T1 true CY1109146T1 (el) 2014-07-02

Family

ID=20286485

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100624T CY1109146T1 (el) 2001-12-27 2009-06-12 Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα

Country Status (21)

Country Link
EP (2) EP1458388B1 (el)
JP (1) JP5264036B2 (el)
KR (1) KR20040075035A (el)
CN (1) CN1607950B (el)
AT (1) ATE427109T1 (el)
AU (1) AU2002359152B2 (el)
BR (1) BR0215393A (el)
CA (1) CA2471906C (el)
CY (1) CY1109146T1 (el)
DE (1) DE60231835D1 (el)
DK (2) DK1458388T3 (el)
ES (2) ES2323228T3 (el)
IL (1) IL162662A0 (el)
MX (1) MXPA04006395A (el)
NZ (1) NZ533714A (el)
PT (2) PT2186507E (el)
RU (1) RU2279871C2 (el)
SE (1) SE0104388D0 (el)
SI (1) SI1458388T1 (el)
WO (1) WO2003055486A1 (el)
ZA (1) ZA200404964B (el)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
JP4708795B2 (ja) 2002-12-20 2011-06-22 ニコノヴァム エービー 物理的および化学的に安定なニコチン−含有粒状物質
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
JP5475215B2 (ja) 2003-02-24 2014-04-16 ファーマシューティカル プロダクションズ， インコーポレイテッド 経粘膜薬物送達システム
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006100075A2 (en) * 2005-03-22 2006-09-28 Niconovum Ab Use of an artificial sweetener to enhance absorption of nicotine
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
US9675109B2 (en) 2005-07-19 2017-06-13 J. T. International Sa Method and system for vaporization of a substance
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
EP2027860A1 (en) * 2006-05-08 2009-02-25 Arturo Solis Herrera The use of nicotine, analogues thereof, precursors thereof or derivatives thereof in the treatment of various pathological processes capable of improvement with alpha-msh administered in prophylactic or therapeutic form
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
AU2007302256A1 (en) * 2006-09-27 2008-04-03 Niconovum Ab Directional use
GB2448224B (en) 2007-04-02 2010-09-01 Parkinson S Inst Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20090041800A1 (en) 2007-08-06 2009-02-12 Synosia Therapeutics, Inc. Methods for Treating Dependence
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
AU2010295883B2 (en) 2009-09-16 2015-08-20 Philip Morris Products Sa Improved device and method for delivery of a medicament
WO2011065754A2 (ko) * 2009-11-24 2011-06-03 주식회사 에바코 기화 흡입용 장치, 이에 적용되는 기화 흡입용 조성물 및 그 기화 흡입용 조성물의 기화시키는 방법
KR100955080B1 (ko) * 2009-11-24 2010-04-28 주식회사 에바코 기화 흡입용 조성물 및 장치
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
GB201012090D0 (en) 2010-07-19 2010-09-01 British American Tobacco Co Cellulosic material
ES2543312T3 (es) 2011-02-11 2015-08-18 Batmark Limited Componente para inhalador
MX356624B (es) 2011-03-09 2018-06-06 Chong Corp Sistema de entrega de medicamento.
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
IL291500B2 (en) 2011-08-16 2024-03-01 Juul Labs Inc Low temperature electronic evaporation device and methods
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9668969B1 (en) 2012-02-22 2017-06-06 Arturo Solis Herrera Methods of using QIAPINE
US20130255702A1 (en) 2012-03-28 2013-10-03 R.J. Reynolds Tobacco Company Smoking article incorporating a conductive substrate
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
CN102960852B (zh) * 2012-11-14 2015-04-22 湖北中烟工业有限责任公司 淡雅香型电子烟雾化烟液及其制备方法
US10034988B2 (en) 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
EP2993999B1 (en) * 2013-05-06 2021-01-27 Juul Labs, Inc. Nicotine salt formulations for electronic cigarettes and method of delivering nicotine
WO2014201432A1 (en) 2013-06-14 2014-12-18 Ploom, Inc. Multiple heating elements with separate vaporizable materials in an electric vaporization device
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
US10194693B2 (en) 2013-09-20 2019-02-05 Fontem Holdings 1 B.V. Aerosol generating device
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
CN105979805B (zh) 2013-12-05 2021-04-16 尤尔实验室有限公司 用于气雾剂装置的尼古丁液体制剂及其方法
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US9549573B2 (en) 2013-12-23 2017-01-24 Pax Labs, Inc. Vaporization device systems and methods
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
HRP20211514T1 (hr) 2013-12-23 2021-12-24 Juul Labs International Inc. Sustavi uređaja za isparavanje
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
CN103750539B (zh) * 2014-01-21 2016-03-23 江苏中烟工业有限责任公司 一种消炎抗菌型烟草鼻腔喷剂组合物及其制备方法
CN103798952B (zh) * 2014-01-21 2016-04-27 江苏中烟工业有限责任公司 通窍提神型烟草鼻腔喷剂组合物及其制备方法
CA2948851A1 (en) 2014-05-16 2015-11-19 Pax Labs, Inc. Systems and methods for aerosolizing a smokeable material
CN105433428A (zh) * 2014-09-01 2016-03-30 上海羿康生物科技有限公司 含咖啡因雾化液及含咖啡因雾化液的生产方法
KR101506708B1 (ko) 2014-09-03 2015-03-30 주식회사 다림바이오텍 금연 보조용 설하분무제와 트로키를 제조하는 방법 및 이에 의하여 제조된 설하분무제와 트로키
EP4233570A3 (en) 2014-10-03 2023-10-18 Fertin Pharma A/S Electronic nicotine delivery system
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
JP6802792B2 (ja) 2014-12-05 2020-12-23 ジュール・ラブズ・インコーポレイテッドＪｕｕｌ Ｌａｂｓ， Ｉｎｃ． 調整された投与量の制御
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
EP3267875A4 (en) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Craving input and support system
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
CN105361238A (zh) * 2015-12-16 2016-03-02 浙江中烟工业有限责任公司 一种含pH调节剂的电子烟烟液及提高电子烟烟液抽吸感的方法
SG10202108578XA (en) 2016-02-11 2021-09-29 Juul Labs Inc Securely attaching cartridges for vaporizer devices
WO2017139595A1 (en) 2016-02-11 2017-08-17 Pax Labs, Inc. Fillable vaporizer cartridge and method of filling
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
KR200486087Y1 (ko) 2016-09-02 2018-04-03 삼성중공업 주식회사 방연 댐퍼 유닛의 풀링 와이어 관통관
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
CN106727449A (zh) * 2016-12-20 2017-05-31 大连丹特生物技术有限公司 一种木糖醇烟碱喷剂及其制备方法
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US20180228203A1 (en) * 2017-02-16 2018-08-16 Altria Client Services Llc Pre-vapor formulation for formation of organic acids during operation of an e-vaping device
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
EP3906916A1 (en) 2017-12-08 2021-11-10 Fertin Pharma A/S Nicotine tablet
CA3085066C (en) * 2017-12-08 2024-01-09 Fertin Pharma A/S Formulations providing high nicotine concentrations
CA3085065C (en) * 2017-12-08 2023-12-05 Fertin Pharma A/S Formulations providing high nicotine concentrations
WO2019110074A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Nicotine mouth spray
US11957786B2 (en) * 2018-02-12 2024-04-16 TPRX Tech, LLC Liquid vape base and extraction process
CN108185539B (zh) * 2018-03-21 2021-03-05 福建中烟工业有限责任公司 一种感官质量得到改善的电子烟及其制作方法
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
GB201817862D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
CN110236958B (zh) * 2019-06-28 2020-12-29 武汉大学 一种用于促进牙齿缺损缺失组织修复的材料及其制备方法
CN110946319A (zh) * 2019-11-20 2020-04-03 许达勇 一种烟碱推进剂及其制备方法
CA3161546A1 (en) 2019-12-15 2021-06-24 Imad Lahoud Mist inhaler devices
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
WO2021123867A1 (en) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US20240148053A9 (en) 2019-12-15 2024-05-09 Shaheen Innovations Holding Limited Hookah device
US11944120B2 (en) 2019-12-15 2024-04-02 Shaheen Innovations Holding Limited Ultrasonic mist inhaler with capillary retainer
EP4292632A3 (en) 2019-12-15 2024-02-28 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
BR102020002169A2 (pt) * 2020-01-31 2021-08-10 Bruno Ghizoni Da Silva Comércio De Produtos E Serviços Inovadores-Me Bebida estimulante
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4721618A (en) 1983-06-27 1988-01-26 Queen's University At Kingston Method for controlling bleeding
US4536392A (en) 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
DE3645036A1 (de) * 1986-11-18 1989-01-05 Forschungsgesellschaft Rauchen Nikotinhaltiges mittel
GB9111224D0 (en) * 1991-05-24 1991-07-17 Charwell Consumer Prod Smoking substitute preparation
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US6211194B1 (en) * 1998-04-30 2001-04-03 Duke University Solution containing nicotine
FR2792200B3 (fr) * 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer

Also Published As

Publication number Publication date
AU2002359152B2 (en) 2006-11-09
PT1458388E (pt) 2009-05-15
ZA200404964B (en) 2005-11-30
EP1458388B1 (en) 2009-04-01
EP1458388A1 (en) 2004-09-22
CN1607950A (zh) 2005-04-20
DK2186507T3 (en) 2015-06-15
ES2537334T3 (es) 2015-06-05
AU2002359152A1 (en) 2003-07-15
BR0215393A (pt) 2004-12-07
RU2004119434A (ru) 2005-04-20
JP5264036B2 (ja) 2013-08-14
CA2471906C (en) 2012-10-16
KR20040075035A (ko) 2004-08-26
SI1458388T1 (sl) 2009-08-31
NZ533714A (en) 2005-04-29
ES2323228T3 (es) 2009-07-09
EP2186507A3 (en) 2011-08-10
MXPA04006395A (es) 2004-10-04
EP2186507A2 (en) 2010-05-19
CA2471906A1 (en) 2003-07-10
IL162662A0 (en) 2005-11-20
RU2279871C2 (ru) 2006-07-20
WO2003055486A1 (en) 2003-07-10
CN1607950B (zh) 2010-04-14
EP2186507B1 (en) 2015-04-01
PT2186507E (pt) 2015-06-24
SE0104388D0 (sv) 2001-12-27
DK1458388T3 (da) 2009-07-13
ATE427109T1 (de) 2009-04-15
JP2005518392A (ja) 2005-06-23
DE60231835D1 (de) 2009-05-14

Similar Documents

Publication Publication Date Title
CY1109146T1 (el) Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα
SE0201669D0 (sv) New formulation and use thereof
SE0102276D0 (sv) Device and method for the administration of a medicament
FI964593A (fi) Oraalisia nestemäisiä alendronaattikokoonpanoja
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
WO2003032928A3 (en) Therapeutic composition and use
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
ATE353645T1 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
DK1378267T3 (da) Anvendelse af flumazenil til fremstilling af et medikament til behandling af kokainafhængighed
ATE419012T1 (de) Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
WO2001060278A3 (en) Oral therapeutic delivery appliance
HUP0301119A2 (hu) Bioaktiváló hatóanyag és gyógyszerkészítmény
BR9914096A (pt) Forma de dosagem oral, distinta, método para prevenir ou tratar distúrbio hipercinético de déficit de atenção ou depressão, uso de uma forma de dosagem oral distinta, e, método para tratar vìcio de produtos contendo nicotina
HUP0002905A2 (hu) 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása
HU0500745D0 (en) Rapidly decomposable pharmaceutical dosage form for use in oral or body cavity containing nicotine as active ingredient
SE0100603D0 (sv) Förfarande och anordning för administration av aktivt ämne till ett hålrum i människokroppen
DE60003921D1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung